Rossari Biotech Ltd vs Sree Rayalaseema Hi Strength Hypo Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Rossari Biotech Ltd is ₹ 410 as of 20 Mar 15:30 . The P/E Ratio of Rossari Biotech Ltd changed from 67.2 on March 2021 to 24.5 on March 2025 . This represents a CAGR of -18.27% over 5 yearsThe P/E Ratio of Sree Rayalaseema Hi-Strength Hypo Ltd changed from 6.7 on March 2021 to 9.4 on March 2025 . This represents a CAGR of 7.01% over 5 years The Market Cap of Rossari Biotech Ltd changed from ₹ 5388 crore on March 2021 to ₹ 3344 crore on March 2025 . This represents a CAGR of -9.10% over 5 yearsThe Market Cap of Sree Rayalaseema Hi-Strength Hypo Ltd changed from ₹ 405.69 crore on March 2021 to ₹ 845.2 crore on March 2025 . This represents a CAGR of 15.81% over 5 years The revenue of Rossari Biotech Ltd for the Dec '25 is ₹ 582.59 crore as compare to the Sep '25 revenue of ₹ 588.18 crore. This represent the decline of -0.95% The revenue of Sree Rayalaseema Hi-Strength Hypo Ltd for the Dec '25 is ₹ 160.58 crore as compare to the Sep '25 revenue of ₹ 189.49 crore. This represent the decline of -15.26% The ebitda of Rossari Biotech Ltd for the Dec '25 is ₹ 69.78 crore as compare to the Sep '25 ebitda of ₹ 74 crore. This represent the decline of -5.7% The ebitda of Sree Rayalaseema Hi-Strength Hypo Ltd for the Dec '25 is ₹ 36.45 crore as compare to the Sep '25 ebitda of ₹ 34.05 crore. This represent the growth of 7.05% The net profit of Rossari Biotech Ltd changed from ₹ 34.9 crore to ₹ 32.77 crore over 7 quarters. This represents a CAGR of -3.53% The net profit of Sree Rayalaseema Hi-Strength Hypo Ltd changed from ₹ 18.62 crore to ₹ 23.75 crore over 7 quarters. This represents a CAGR of 14.92% The Dividend Payout of Rossari Biotech Ltd changed from 3.28 % on March 2021 to 2.41 % on March 2025 . This represents a CAGR of -5.98% over 5 yearsThe Dividend Payout of Sree Rayalaseema Hi-Strength Hypo Ltd changed from 8.5 % on March 2021 to 5.55 % on March 2025 . This represents a CAGR of -8.17% over 5 years .

About Rossari Biotech Ltd

Rossari Biotech Limited was founded in 2003 as a partnership firm in the name of Rossari Labtech by Mr. Edward Walter Menezes, and Mr. Sunil Srinivasan Chari, who are both career-technocrats cumulatively having over 45 years of experience in the specialty chemicals industry.
It was further renamed to Rossari Biotech Limited and converted into a company in 2009.
The Company has two state-of-the art facilities at Dahej, Gujarat and Silvassa, Dadra Nagar & Haveli and is mainly engaged in manufacturing, selling and distribution of specialty chemicals.
The products cater to global brands in the FMCG sector and find applications in a host of consumer-centric products and home and personal care products, textile chemicals, animal health and nutrition and cosmetic products. During the FY2020, 50,00,000 equity shares of face value of Rs 10 each was sub-divided into 2,50,00,000 Equity Shares of face value of Rs 2 each.

About Sree Rayalaseema Hi-Strength Hypo Ltd

Sree Rayalaseema Hi-Strength Hypo Limited was incorporated in March, 2005.
The Company is the leading producer of Calcium Hypo Chloride, Stable Bleaching Powder, Sulphuric Acid and Other Chemicals. Sree Rayalaseema Hi-Strength Hypo, the torch bearer of the conglomerate, is the only Indian manufacturer of Calcium Hypochlorite, and one of the very few in the world.
A state-of-the-art sodium process technology developed through in-house R&D efforts helps the company in manufacturing the product with a chlorine content of 65% to 70%. The business of manufacturing of industrial chemicals was vested in the Company effective on 1st April, 2005 through Scheme of Arrangement in June, 2006 and generation of Wind Energy in 2008. The Company products can be broadly classified under Inorganic chemicals.

FAQs for the comparison of Rossari Biotech Ltd and Sree Rayalaseema Hi-Strength Hypo Ltd

Which company has a larger market capitalization, Rossari Biotech Ltd or Sree Rayalaseema Hi-Strength Hypo Ltd?

Market cap of Rossari Biotech Ltd is 2,270 Cr while Market cap of Sree Rayalaseema Hi-Strength Hypo Ltd is 742 Cr

What are the key factors driving the stock performance of Rossari Biotech Ltd and Sree Rayalaseema Hi-Strength Hypo Ltd?

The stock performance of Rossari Biotech Ltd and Sree Rayalaseema Hi-Strength Hypo Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Rossari Biotech Ltd and Sree Rayalaseema Hi-Strength Hypo Ltd?

As of March 23, 2026, the Rossari Biotech Ltd stock price is INR ₹410.0. On the other hand, Sree Rayalaseema Hi-Strength Hypo Ltd stock price is INR ₹432.75.

How do dividend payouts of Rossari Biotech Ltd and Sree Rayalaseema Hi-Strength Hypo Ltd compare?

To compare the dividend payouts of Rossari Biotech Ltd and Sree Rayalaseema Hi-Strength Hypo Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.